This article has been corrected from an earlier version to reflect the settlement of both suits, not just one, between Invitrogen and Bio-Rad.
Invitrogen and Bio-Rad Laboratories have reached settlements in two patent infringement suits filed by Invitrogen alleging that some of Bio-Rad’s products infringed upon certain Invitrogen patents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.